<DOC>
	<DOCNO>NCT00733265</DOCNO>
	<brief_summary>The main purpose study examine AZD6140 affect patient severe kidney disease compare volunteer normal kidney . Subjects study receive one dose AZD6140 .</brief_summary>
	<brief_title>Study Investigate Effects AZD6140 Patients With Renal Impairment Healthy Volunteers</brief_title>
	<detailed_description />
	<mesh_term>Renal Insufficiency</mesh_term>
	<mesh_term>Ticagrelor</mesh_term>
	<criteria>Patients must severe kidney disease Subjects match kidney disease patient term weight , age , sex must normal kidneys All woman must postmenopausal ( longer menstruate ) surgically sterile Patients require dialysis History allergy aspirin clopidogrel Have increase bleeding risk ( instance uncontrolled high blood pressure recent major injury ) Recent history fainting lightheadedness</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>December 2010</verification_date>
	<keyword>Renal Impairment</keyword>
</DOC>